Skip to main content

Table 1 Description of the study cohorta

From: NMR derived changes of lipoprotein particle concentrations related to impaired fasting glucose, impaired glucose tolerance, or manifest type 2 diabetes mellitus

oGTT group

All (N = 595)

Control ( N = 251)

IFG ( N = 193)

IGT ( N = 26)

IFG + IGT ( N = 68)

T2D ( N = 57)

Male

380

140

130

18

45

47

Female

215

111

63

8

23

10

Age [years]

54.3 ± 8.9

52.8 ± 10.1

54.6 ± 7.9

57.2 ± 7.7

56 ± 8.1

56.4 ± 7.0

BMI [kg/m2]

28.8 ± 4.1

27.9 ± 4.0

29.0 ± 3.8

29.4 ± 3.5

30.3 ± 4.3

30.4 ± 4.3

HbA1c [%]

5.9 ± 0.4

5.8 ± 0.2

5.9 ± 0.3

5.9 ± 0.4

6 ± 0.3

6.3 ± 0.7

FindRisk Score [a.u]

12.5 ± 3.6

11.4 ± 3.8

12.9 ± 3.3

12.7 ± 2.8

14 ± 3.0

13.7 ± 3.4

c ( t = 0)a [mg/dL]

103.4 ± 13.4

93.8 ± 4.7

106.7 ± 5.6

95.2 ± 3.9

109.9 ± 6.6

130.3 ± 18.8

c (t = 120)b [mg/dL]

122.1 ± 43.6

101.2 ± 20.6

106.2 ± 20.3

155.3 ± 14.6

163.8 ± 17.2

210.9 ± 61.4

  1. aConcentration of glucose in the oGTT at t = 0 min
  2. bConcentration of glucose in the oGTT at t = 120 min